Agonist-induced [Ca2+]i waves and Ca(2+)-induced Ca2+ release in mammalian vascular smooth muscle cells

1992 ◽  
Vol 263 (2) ◽  
pp. H576-H586 ◽  
Author(s):  
L. A. Blatter ◽  
W. G. Wier

Focal application of vasopressin to cultured vascular smooth muscle cells (A7r5 cells) elicits first a localized increase of intracellular Ca2+ concentration ([Ca2+]i) and then a wave of elevated [Ca2+]i that propagates at constant velocity throughout the cell. The cellular mechanisms of such complex spatiotemporal patterns of [Ca2+]i are of interest because they are involved fundamentally in cellular signal transduction in many types of cells. Vasopressin evoked a [Ca2+]i transient even in the absence of extracellular Ca2+, and intracellular perfusion with heparin completely blocked the response to vasopressin stimulation. Therefore the initial response to vasopressin reflects release of Ca2+ from an intracellular myo-inositol-1,4,5-trisphosphate (IP3)-sensitive Ca2+ store. We tested four hypotheses on how a localized increase in [Ca2+]i propagates as a [Ca2+]i wave throughout the entire cell: the hypotheses distinguished 1) whether IP3 or Ca2+ is the primary intracellular messenger that diffuses, and 2) whether positive feedback on the release of intracellular Ca2+ (Ca2+i) is involved (further release of Ca2+ through activation of phospholipase C by Ca2+ and increased production of IP3 or by Ca(2+)-induced Ca2+ release). The results of various experimental interventions, which included probing Ca2+i stores (heparin, caffeine, and ryanodine), were compared with predictions from mathematical models for intracellular diffusion, release, and uptake of Ca2+. We conclude that in A7r5 smooth muscle cells, which have been stimulated focally with vasopressin, Ca2+ is released initially by IP3. The localized increase in [Ca2+]i then propagates throughout the cell as a [Ca2+]i wave. Ca2+ activates its own release, through Ca(2+)-induced release of Ca2+, by diffusing to distant Ca(2+)-release sites.

1984 ◽  
Vol 247 (6) ◽  
pp. E822-E826 ◽  
Author(s):  
R. C. Stanton ◽  
S. B. Plant ◽  
D. A. McCarron

Parathyroid hormone (PTH) is a vasodilator of vascular smooth muscle tissue. It has been shown to produce this vasodilation in normotensive and hypertensive laboratory rats. The effect is log dose dependent, maximal at 1 min and persists for 3–5 min. The cellular mechanisms involved in PTH-mediated vasodilation are unknown. In this study, we sought to determine the cellular changes of cAMP after administration of bovine (b)PTH (1–34). cAMP content of vascular smooth muscle cells was measured at 30 s, 1, 3, and 5 min after incubation with synthetic bPTH (1–34). Tissue cAMP content was decreased by 55% at 1 min (4.1 +/- 0.5 pmol/mg protein at time 0 vs. 1.9 +/- 0.2 pmol/mg protein at 1 min, P less than 0.001). After 5 min, cAMP levels returned to base-line values and increased over the next 5–10 min to levels above base line (P less than 0.01). In conclusion, our data suggest that the initial response of vascular smooth muscle cells to short-term incubation with bPTH (1–34) is an acute decrease in cAMP content.


2001 ◽  
Vol 280 (3) ◽  
pp. C593-C603 ◽  
Author(s):  
Wah-Lun Chan ◽  
N.-H. Holstein-Rathlou ◽  
Kay-Pong Yip

Peptides with the Arg-Gly-Asp (RGD) motif induce vasoconstriction in rat afferent arterioles by increasing the intracellular Ca2+ concentration ([Ca2+]i) in vascular smooth muscle cells (VSMC). This finding suggests that occupancy of integrins on the plasma membrane of VSMC might affect vascular tone. The purpose of this study was to determine whether occupancy of integrins by exogenous RGD peptides initiates intracellular Ca2+ signaling in cultured renal VSMC. When smooth muscle cells were exposed to 0.1 mM hexapeptide GRGDSP, [Ca2+]i rapidly increased from 91 ± 4 to 287 ± 37 nM and then returned to the baseline within 20 s (P < 0.05, 34 cells/5 coverslips). In controls, the hexapeptide GRGESP did not trigger Ca2+mobilization. Local application of the GRGDSP induced a regional increase of cytoplasmic [Ca2+]i, which propagated as Ca2+ waves traveling across the cell and induced a rapid elevation of nuclear [Ca2+]i. Spontaneous recurrence of smaller-amplitude Ca2+ waves were found in 20% of cells examined after the initial response to RGD-containing peptides. Blocking dihydropyridine-sensitive Ca2+ channels with nifedipine or removal of extracellular Ca2+ did not inhibit the RGD-induced Ca2+mobilization. However, pretreatment of 20 μM ryanodine completely eliminated the RGD-induced Ca2+ mobilization. Anti-β1 and anti-β3-integrin antibodies with functional blocking capability simulate the effects of GRGDSP in [Ca2+]i. Incubation with anti-β1- or β3-integrin antibodies inhibited the increase in [Ca2+]i induced by GRGDSP. We conclude that exogenous RGD-containing peptides induce release of Ca2+ from ryanodine-sensitive Ca2+stores in renal VSMC via integrins, which can trigger cytoplasmic Ca2+ waves propagating throughout the cell.


Toxins ◽  
2020 ◽  
Vol 12 (1) ◽  
pp. 58 ◽  
Author(s):  
Britt Opdebeeck ◽  
Patrick C. D’Haese ◽  
Anja Verhulst

The protein-bound uremic toxins, indoxyl sulfate (IS) and p-cresyl sulfate (PCS), are considered to be harmful vascular toxins. Arterial media calcification, or the deposition of calcium phosphate crystals in the arteries, contributes significantly to cardiovascular complications, including left ventricular hypertrophy, hypertension, and impaired coronary perfusion in the elderly and patients with chronic kidney disease (CKD) and diabetes. Recently, we reported that both IS and PCS trigger moderate to severe calcification in the aorta and peripheral vessels of CKD rats. This review describes the molecular and cellular mechanisms by which these uremic toxins induce arterial media calcification. A complex interplay between inflammation, coagulation, and lipid metabolism pathways, influenced by epigenetic factors, is crucial in IS/PCS-induced arterial media calcification. High levels of glucose are linked to these events, suggesting that a good balance between glucose and lipid levels might be important. On the cellular level, effects on endothelial cells, which act as the primary sensors of circulating pathological triggers, might be as important as those on vascular smooth muscle cells. Endothelial dysfunction, provoked by IS and PCS triggered oxidative stress, may be considered a key event in the onset and development of arterial media calcification. In this review a number of important outstanding questions such as the role of miRNA’s, phenotypic switching of both endothelial and vascular smooth muscle cells and new types of programmed cell death in arterial media calcification related to protein-bound uremic toxins are put forward and discussed.


2001 ◽  
Vol 281 (4) ◽  
pp. H1545-H1552 ◽  
Author(s):  
Jerry G. Webb ◽  
Phillip W. Yates ◽  
Qing Yang ◽  
Yurii V. Mukhin ◽  
Stephen M. Lanier

Adenylyl cyclases present a potential focal point for signal integration in vascular smooth muscle cells (VSMC) influencing contractile state and cellular responses to vessel wall injury. In the present study, we examined the influence of the vasoactive peptide arginine vasopressin (AVP) on cAMP regulation in primary cultures of rat aortic VSMC and in the A7r5 arterial smooth muscle cell line. In cultured VSMC and A7r5 cells, AVP had no effect on basal cAMP but differentially affected β-adrenergic receptor-induced activation of adenylyl cyclase. AVP synergistically increased (twofold) isoproterenol-stimulated cAMP production in VSMC but inhibited the effect of isoproterenol (50%) in the A7r5 cell line. The effects of AVP in both preparations were blocked when cells were pretreated with a selective V1vasopressin receptor antagonist. Moreover, the actions of AVP in both models were dependent on release of intracellular Ca2+ and were mimicked by elevation of Ca2+ with the ionophore A23187 , suggesting that the responses to AVP involve Ca2+-mediated regulation of adenylyl cyclase stimulation. Adenylyl cyclase types I, III, and VIII are stimulated by Ca2+/calmodulin, whereas types V and VI are directly inhibited by Ca2+. RNA blot analysis for effector isotypes indicated that both VSMC and A7r5 cells expressed types III, V, and VI. VSMC also expressed mRNA for type IV and VIII effectors, which could account for the cell-specific responses to peptide hormone and Ca2+.


1992 ◽  
Vol 263 (4) ◽  
pp. C873-C878 ◽  
Author(s):  
K. Okada ◽  
S. Ishikawa ◽  
T. Saito

The present study was undertaken to examine the effects of arginine vasopressin (AVP) and endothelin-1 (ET-1) on cytosolic free Mg2+ ([Mg2+]i) in cultured rat vascular smooth muscle cells (VSMC). [Mg2+]i was measured using the fluorescence indicator dye mag-fura-2. AVP and ET-1 at a concentration of 1 x 10(-9) M or higher induced the mobilization of [Mg2+]i and cytosolic free Ca2+ ([Ca2+]i) in a dose-dependent manner in rat VSMC. Atrial natriuretic peptide and sodium nitroprusside producing cellular guanosine 3',5'-cyclic monophosphate did not affect [Mg2+]i and [Ca2+]i. A diterpene activator of adenylate cyclase, forskolin, also did not alter [Mg2+]i and [Ca2+]i. The removal of extracellular Mg2+ enhanced the AVP-mobilized [Ca2+]i and did not change the AVP-mobilized [Mg2+]i. The Ca(2+)-free and nominally Mg2+/Ca(2+)-free states decreased the AVP-mobilized [Mg2+]i and [Ca2+]i. The Na(+)-free state enhanced the sustained, but not peak, level of the AVP-mobilized [Mg2+]i. These results indicate that AVP and ET-1 mobilize [Mg2+]i mediated through their intracellular second messenger [Ca2+]i and independent of extracellular Mg2+. Also, an increase in [Mg2+]i is indicated to stimulate the Na(+)-Mg2+ exchange to increase cellular Mg2+ efflux.


1993 ◽  
Vol 22 (Supplement 2) ◽  
pp. S16-S19 ◽  
Author(s):  
Harald Meyer-Lehnert ◽  
Christine Wanning ◽  
Harald Michel ◽  
Angela Bäcker ◽  
Herbert J. Kramer

1991 ◽  
Vol 274 (3) ◽  
pp. 799-805 ◽  
Author(s):  
B C Berk ◽  
M B Taubman ◽  
K K Griendling ◽  
E J Cragoe ◽  
J W Fenton ◽  
...  

Thrombin is present in high concentrations at sites of clots and may have important post-clotting effects on adjacent vascular tissue. This may be particularly important for vascular smooth-muscle cells (VSMC), whose growth and contractility are altered following atherosclerotic-associated thromboses. To study the cellular signal events by which thrombin exerts its actions, the effects of purified human alpha-thrombin were examined in cultured rat aortic VSMC. alpha-Thrombin stimulated a biphasic change in intracellular pH (pHi), causing an early rapid acidification, followed by a sustained alkalinization. The increase in pHi was dependent on extracellular Na+ and inhibited by 5′-(NN-dimethyl)amiloride, consistent with mediation by Na+/H+ exchange. alpha-Thrombin rapidly increased free intracellular [Ca2+] ([Ca2+]i). The increase in [Ca2+]i was secondary to activation of phospholipase C, as demonstrated by increases in InsP3 (226%) and InsP2 (387%) and decreases in polyphosphoinositides at 15 s. Expression of the mRNA for the proto-oncogene c-fos was induced by alpha-thrombin. Stimulation of c-fos mRNA was not dependent on alterations in pHi, but required a rise in [Ca2+]i. Despite many growth-related signals shared by alpha-thrombin with platelet-derived growth factor, alpha-thrombin failed to stimulate [3H]thymidine incorporation or cell division, although there was a maximal increase of 52% in protein synthesis. The data suggest that there are cellular signal events not activated by alpha-thrombin which are required for proliferation of these aortic VSMC.


2008 ◽  
Vol 294 (5) ◽  
pp. H2060-H2068 ◽  
Author(s):  
Hong Hui Wang ◽  
Hideyuki Tanaka ◽  
Xiaoran Qin ◽  
Tiejun Zhao ◽  
Li-Hong Ye ◽  
...  

Blebbistatin is a myosin II-specific inhibitor. However, the mechanism and tissue specificity of the drug are not well understood. Blebbistatin blocked the chemotaxis of vascular smooth muscle cells (VSMCs) toward sphingosylphosphorylcholine (IC50 = 26.1 ± 0.2 and 27.5 ± 0.5 μM for GbaSM-4 and A7r5 cells, respectively) and platelet-derived growth factor BB (IC50 = 32.3 ± 0.9 and 31.6 ± 1.3 μM for GbaSM-4 and A7r5 cells, respectively) at similar concentrations. Immunofluorescence and fluorescent resonance energy transfer analysis indicated a blebbistatin-induced disruption of the actin-myosin interaction in VSMCs. Subsequent experiments indicated that blebbistatin inhibited the Mg2+-ATPase activity of the unphosphorylated (IC50 = 12.6 ± 1.6 and 4.3 ± 0.5 μM for gizzard and bovine stomach, respectively) and phosphorylated (IC50 = 15.0 ± 0.6 μM for gizzard) forms of purified smooth muscle myosin II, suggesting a direct effect on myosin II motor activity. It was further observed that the Mg2+-ATPase activities of gizzard myosin II fragments, heavy meromyosin (IC50 = 14.4 ± 1.6 μM) and subfragment 1 (IC50 = 5.5 ± 0.4 μM), were also inhibited by blebbistatin. Assay by in vitro motility indicated that the inhibitory effect of blebbistatin was reversible. Electron-microscopic evaluation showed that blebbistatin induced a distinct conformational change (i.e., swelling) of the myosin II head. The results suggest that the site of blebbistatin action is within the S1 portion of smooth muscle myosin II.


Sign in / Sign up

Export Citation Format

Share Document